Literature DB >> 29745381

Retraction Note to: The BRCA2 variant c.68-7 T > A is associated with breast cancer.

Pål Møller1,2,3, Eivind Hovig2,4,5.   

Abstract

[This retracts the article DOI: 10.1186/s13053-017-0080-y.].

Entities:  

Year:  2018        PMID： 29745381      PMCID： PMC5930441          DOI： 10.1186/s13053-018-0093-1

Source DB:  PubMed          Journal:  Hered Cancer Clin Pract        ISSN： 1731-2302            Impact factor:   2.857


Retraction

This article [1] has been retracted at the request of the authors. Upon re-review of the data, the authors identified coding errors in this study. Due to an error in the SQL query, the conclusions drawn in the article are incorrect. A re-examination of the data shows that there is no association between familial breast cancer and the BRCA2 variant c.68–7 T > A. Another recent study suggests that the variant is not pathogenic [2]. All authors agree to this retraction.
  2 in total

1.  The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.

Authors:  Mara Colombo; Irene Lòpez-Perolio; Huong D Meeks; Laura Caleca; Michael T Parsons; Hongyan Li; Giovanna De Vecchi; Emma Tudini; Claudia Foglia; Patrizia Mondini; Siranoush Manoukian; Raquel Behar; Encarna B Gómez Garcia; Alfons Meindl; Marco Montagna; Dieter Niederacher; Ane Y Schmidt; Liliana Varesco; Barbara Wappenschmidt; Manjeet K Bolla; Joe Dennis; Kyriaki Michailidou; Qin Wang; Kristiina Aittomäki; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Matthias W Beckmann; Alicia Beeghly-Fadel; Javier Benitez; Bram Boeckx; Natalia V Bogdanova; Stig E Bojesen; Bernardo Bonanni; Hiltrud Brauch; Hermann Brenner; Barbara Burwinkel; Jenny Chang-Claude; Don M Conroy; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Peter Devilee; Thilo Dörk; Mikael Eriksson; Peter A Fasching; Jonine Figueroa; Olivia Fletcher; Henrik Flyger; Marike Gabrielson; Montserrat García-Closas; Graham G Giles; Anna González-Neira; Pascal Guénel; Christopher A Haiman; Per Hall; Ute Hamann; Mikael Hartman; Jan Hauke; Antoinette Hollestelle; John L Hopper; Anna Jakubowska; Audrey Jung; Veli-Matti Kosma; Diether Lambrechts; Loid Le Marchand; Annika Lindblom; Jan Lubinski; Arto Mannermaa; Sara Margolin; Hui Miao; Roger L Milne; Susan L Neuhausen; Heli Nevanlinna; Janet E Olson; Paolo Peterlongo; Julian Peto; Katri Pylkäs; Elinor J Sawyer; Marjanka K Schmidt; Rita K Schmutzler; Andreas Schneeweiss; Minouk J Schoemaker; Mee Hoong See; Melissa C Southey; Anthony Swerdlow; Soo H Teo; Amanda E Toland; Ian Tomlinson; Thérèse Truong; Christi J van Asperen; Ans M W van den Ouweland; Lizet E van der Kolk; Robert Winqvist; Drakoulis Yannoukakos; Wei Zheng; Alison M Dunning; Douglas F Easton; Alex Henderson; Frans B L Hogervorst; Louise Izatt; Kenneth Offitt; Lucy E Side; Elizabeth J van Rensburg; Study Embrace; Study Hebon; Lesley McGuffog; Antonis C Antoniou; Georgia Chenevix-Trench; Amanda B Spurdle; David E Goldgar; Miguel de la Hoya; Paolo Radice
Journal:  Hum Mutat       Date:  2018-04-06       Impact factor: 4.878

2.  The BRCA2 variant c.68-7 T>A is associated with breast cancer.

Authors:  Pål Møller; Eivind Hovig
Journal:  Hered Cancer Clin Pract       Date:  2017-11-13       Impact factor: 2.857
  2 in total
  1 in total

1.  Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health care and medicine.

Authors:  Birgitta Haga Gripsrud; Kari Nyheim Solbrække
Journal:  Med Health Care Philos       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.